CD28 antibody
Principal name
CD28 antibody
Alternative names for CD28 antibody
TP44, T-cell-specific surface glycoprotein CD28
SwissProt ID
O02757 (Felca), P10747 (Human), P31041 (Mouse), P31042 (Rat), P31043 (Chick), P42069 (Rabit), Q28071 (Bovin)
Ncbi ID
NP_037253.1, 10090, NP_006130.1, 9606, NP_990642.1, NP_006130, NP_037253, AAH93698.1, NM_006139, NP_031668.3, NM_007642, NM_013121
Available reactivities
Available hosts
Available applications
Flow Cytometry (F), Frozen Sections (C), Functional assay (FN), Immunoprecipitation (IP), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of CD28 antibody
Human CD28 antigen is a 44 kDa disulfide linked homodimeric T cell specific surface glycoprotein. It is a cell adhesion molecule of the immunoglobulin superfamily which is constitutively expressed on most peripheral blood T lymphocytes (approximately 95% of CD4+ cells and 50% of CD8+ cells). Mature thymocytes exhibit higher levels of CD28 than the immature cells. Activation of T cells results in enhanced CD28 expression. T cell activation requires two combined signals provided by antigen presenting cells. The first is mediated via the T cell receptor following its interaction with antigenic peptide MHC complexes, and the second is delivered by accessory or costimulating molecules through their counter receptors on T lymphocytes. CD28 bears structural homology to CTLA 4 which is expressed at very low levels on the surface of CD4+ and CD8+ peripheral blood cells only following activation. CD28 is the natural receptor for the B7/BB 1 ligand (CD80) a 55-60 kDa glycoprotein which is expressed on activated B lymphocytes, on dendritic cells and on interferon gamma treated monocytes. The binding of B7 1/BB 1 molecules to CD28 is involved in T lymphocyte activation and in the initiation and maintenance of chronic inflammation.
General readings
1. Nunès J, Klasen S, Ragueneau M, Pavon C, Couez D, Mawas C, Bagnasco M, Olive D: CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int Immunol. 1993 Mar;5(3):311-5.
2. Nunes J, Klasen S, Franco MD, Lipcey C, Mawas C, Bagnasco M, Olive D: Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochem J. 1993 Aug 1;293 ( Pt 3):835-42.
3. Schlossman, S., et al., Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
4. Galea-Lauri J, Darling D, Gan SU, Krivochtchapov L, Kuiper M, Gäken J, Souberbielle B, Farzaneh F: Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J Immunol. 1999 Jul 1;163(1):62-70.
5. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P: Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol. 1999 Sep 15;163(6):3511-5.
6. Marti F, Krause A, Post NH, Lyddane C, Dupont B, Sadelain M, King PD: Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J Immunol. 2001 Jan 1;166(1):197-206.
7. Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D: Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol. 2004 May;24(9):3860-73.
8. Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K, Liang TJ. Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol. 2004 Jul;78(13):6995-7003.











- Quick-Filters:
- Cited (1)
- Overnight Delivery (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AM08037PU-N | CD28 antibody |
||||||
![]() |
Hamster | IgG2 | 37.51 | Purified | Ms | F, FN, IP |
0.5 mg /
€310.00
|
| OriGene Technologies GmbH | |||||||
Published recently! |
|||||||
| TA311351 | CD28 (Extracell. Dom.) antibody |
||||||
| Goat Anti-CD28 Antibody | |||||||
![]() |
Goat | Aff - Purified | Hu | E, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA311383 | CD28 antibody |
||||||
| Goat Anti-Cd28 Antibody | |||||||
![]() |
Goat | Aff - Purified | Ms | E, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA320257 | CD28 antibody |
||||||
| Golden Syrian Hamster Anti-Mouse CD28 Purified (100 ug) | |||||||
![]() |
Hamster | 37.51 | Purified | Ms | F, IP, P |
0.1 mg /
€175.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA320258 | CD28 antibody |
||||||
| Mouse Anti-Human CD28 Purified (100 ug) | |||||||
![]() |
Mouse | CD28.2 | Purified | Hu | F, IP, P |
0.1 mg /
€175.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA320259 | CD28 antibody |
||||||
| Mouse Anti-Rat CD28 Purified (500 ug) | |||||||
![]() |
Mouse | JJ319 | Purified | Rt | F, IP |
0.5 mg /
€340.00
|
|
| OriGene Technologies, Inc. | |||||||
| AM05187AC-N | CD28 antibody |
||||||
![]() |
Mouse | IgG1 | B-23 | APC | Hu | F |
100 Tests /
€430.00
|
| OriGene Technologies GmbH | |||||||
| AM08037AC-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | 37.51 | APC | Ms | F |
0.1 mg /
€380.00
|
| OriGene Technologies GmbH | |||||||
| AM08037BT-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | 37.51 | Biotin | Ms | F |
0.5 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM08037FC-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | 37.51 | FITC | Ms | F |
0.5 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM08037LE-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | 37.51 | Low Endotoxin | Ms | F, FN, IP |
0.5 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM08037RP-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | 37.51 | PE | Ms | F |
0.2 mg /
€380.00
|
| OriGene Technologies GmbH | |||||||
| AM08037RP-S | CD28 antibody |
||||||
![]() |
Hamster | IgG | 37.51 | PE | Ms | F |
0.1 mg /
€270.00
|
| OriGene Technologies GmbH | |||||||
| AM08038AC-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | APC | Ms | F |
0.1 mg /
€380.00
|
| OriGene Technologies GmbH | |||||||
| AM08038BT-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | Biotin | Ms | F |
0.5 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM08038FC-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | FITC | Ms | F |
0.5 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM08038LE-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | Low Endotoxin | Ms | F, FN, IP |
0.5 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM08038PU-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | Purified | Ms | F, FN, IP |
0.5 mg /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08038RP-N | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | PE | Ms | F |
0.2 mg /
€380.00
|
| OriGene Technologies GmbH | |||||||
| AM08038RP-S | CD28 antibody |
||||||
![]() |
Hamster | IgG | PV-1 | PE | Ms | F |
0.1 mg /
€270.00
|
| OriGene Technologies GmbH | |||||||




































